Literature DB >> 8362987

Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.

W M Mars1, R Zarnegar, G K Michalopoulos.   

Abstract

Hepatocyte growth factor, also known as scatter factor, is a complete mitogen for hepatocytes that bears sequence and structural homology with plasminogen. Because it exists in both a mitogenically inactive single-chain form and an active two-chain form, we were interested in determining whether plasminogen activators could properly cleave single-chain hepatocyte growth factor to generate active two-chain hepatocyte growth factor. Herein we report that both urokinase-type plasminogen activator and tissue-type plasminogen activator can cleave single-chain hepatocyte growth factor, generating two-chain hepatocyte growth factor. When equal quantities of plasminogen activator-treated and activator-untreated hepatocyte growth factor are compared in serum-free in vitro bioassays, the treated hepatocyte growth factor is mitotically more active. Also, urokinase-type plasminogen activator was inactive against hepatocyte growth factor molecules with a mutated cleavage site. This suggests that urokinase-type and tissue-type plasminogen activator may be natural biological regulators of hepatocyte growth factor. Because the active form of hepatocyte growth factor is a powerful stimulator of DNA synthesis and cell motility, these findings may be relevant in understanding the role of plasminogen activators in the biology of cancer invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8362987      PMCID: PMC1887222     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Transplantation system for determining the clonogenic survival of parenchymal hepatocytes exposed to ionizing radiation.

Authors:  R L Jirtle; G Michalopoulos; J R McLain; J Crowley
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

Review 2.  The role of urokinase-type plasminogen activator in aggressive tumor cell behavior.

Authors:  J E Testa; J P Quigley
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

3.  Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.

Authors:  G Høyer-Hansen; E Rønne; H Solberg; N Behrendt; M Ploug; L R Lund; V Ellis; K Danø
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

4.  Processing of hepatocyte growth factor to the heterodimeric form is required for biological activity.

Authors:  E Gak; W G Taylor; A M Chan; J S Rubin
Journal:  FEBS Lett       Date:  1992-10-12       Impact factor: 4.124

5.  Characterization of the effects of human placental HGF on rat hepatocytes.

Authors:  J Hernandez; R Zarnegar; G K Michalopoulos
Journal:  J Cell Physiol       Date:  1992-01       Impact factor: 6.384

6.  Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer.

Authors:  D Naka; T Ishii; Y Yoshiyama; K Miyazawa; H Hara; T Hishida; N Kidamura
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

7.  Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells.

Authors:  M S Pepper; K Matsumoto; T Nakamura; L Orci; R Montesano
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

8.  Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer.

Authors:  I Bièche; M H Champème; F Matifas; K Hacène; R Callahan; R Lidereau
Journal:  Lancet       Date:  1992-01-18       Impact factor: 79.321

9.  Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor.

Authors:  V Ellis; N Behrendt; K Danø
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

10.  Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding.

Authors:  N A Lokker; M R Mark; E A Luis; G L Bennett; K A Robbins; J B Baker; P J Godowski
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

View more
  101 in total

Review 1.  The past, the future and the biology of memory storage.

Authors:  E R Kandel; C Pittenger
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-12-29       Impact factor: 6.237

2.  The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat.

Authors:  P Pediaditakis; J C Lopez-Talavera; B Petersen; S P Monga; G K Michalopoulos
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

Review 3.  Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.

Authors:  Alessia Locatelli; Kristopher A Lofgren; Andrea R Daniel; Nancy E Castro; Carol A Lange
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

4.  [Subretinal co-application of rtPA and bevacizumab for exudative AMD with submacular hemorrhage. Compatibility and clinical long-term results].

Authors:  J Hillenkamp; A Klettner; S Puls; F Treumer; J Roider
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

5.  tPA activates LDL receptor-related protein 1-mediated mitogenic signaling involving the p90RSK and GSK3beta pathway.

Authors:  Ling Lin; Guojun Bu; Wendy M Mars; W Brian Reeves; Sakae Tanaka; Kebin Hu
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

6.  Tissue Plasminogen Activator: Side Effects and Signaling.

Authors:  Ling Lin; Kebin Hu
Journal:  J Drug Des Res       Date:  2014-09-25

7.  Uptake and distribution of hepatocyte growth factor in normal and regenerating adult rat liver.

Authors:  M L Liu; W M Mars; R Zarnegar; G K Michalopoulos
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

8.  Perioperative hepatocyte growth factor (HGF) infusions improve hepatic regeneration following portal branch ligation (PBL) in rodents.

Authors:  Christopher W Mangieri; Jason C McCartt; Matthew A Strode; John E Lowry; Prasad M Balakrishna
Journal:  Surg Endosc       Date:  2016-10-17       Impact factor: 4.584

9.  Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction.

Authors:  Elizabeth M Powell; Daniel B Campbell; Gregg D Stanwood; Caleb Davis; Jeffrey L Noebels; Pat Levitt
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

Review 10.  Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa.

Authors:  Hiroshi Itoh; Hiroaki Kataoka
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.